What is West Pharmaceutical Services's accrued expenses?

West Pharmaceutical Services (WST) reported accrued expenses of $46.60M in Q1 2026.

What does accrued expenses mean?

Expenses the company has incurred but has not yet received a bill for or paid.

Discontinued — last reported Q3 '19

West Pharmaceutical Services Accrued Expenses increased by 18.9% to $46.60M in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ4 2014

Last reportedQ3 2019

A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.

This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...

Standard current liability found in almost all corporate balance sheets.

Metric ID: accrued_expenses

2 periods

	Q4 '25	Q1 '26
Value	$39.20M	$46.60M
QoQ Change	—	+18.9%

Range$39.20M – $46.60M

What is West Pharmaceutical Services's accrued expenses?: West Pharmaceutical Services (WST) reported accrued expenses of $46.60M in Q1 2026.
What does accrued expenses mean?: Expenses the company has incurred but has not yet received a bill for or paid.